An observational study evaluating efficacy of tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR) in HIV infected patients in clinical practice
Latest Information Update: 23 May 2017
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 23 May 2017 New trial record
- 01 Apr 2017 Results published in the Medicine